Created at	Source	Raw Value	Validated value
Jan. 5, 2025, 10:16 p.m.	usa	Proportion of Patients With Any AE Within 7 d of Study Drug Administration	Proportion of Patients With Any AE Within 7 d of Study Drug Administration
March 26, 2021, 12:31 a.m.	usa	Rate of Adverse Events after a single combined DZIF-10c inhalation and infusion [Safety and Tolerability];Rate of Adverse Events after a single DZIF-10c inhalation [Safety and Tolerability]	Rate of Adverse Events after a single combined DZIF-10c inhalation and infusion [Safety and Tolerability];Rate of Adverse Events after a single DZIF-10c inhalation [Safety and Tolerability]
Nov. 19, 2020, 12:31 a.m.	usa	Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability];Incidence of Reactogenicity Adverse Events [Safety and Tolerability]	Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability];Incidence of Reactogenicity Adverse Events [Safety and Tolerability]